澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - telmisartan, quantity: 80 mg - tablet, uncoated - excipient ingredients: magnesium stearate; mannitol; sodium hydroxide; povidone; polysorbate 80; meglumine; purified water - 1) treatment of hypertension,2) prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - telmisartan, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, multilayer - excipient ingredients: sodium hydroxide; mannitol; povidone; lactose monohydrate; meglumine; magnesium stearate; sodium stearylfumarate; purified water; iron oxide red - mizart hct is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - telmisartan, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, multilayer - excipient ingredients: magnesium stearate; purified water; povidone; sodium stearylfumarate; mannitol; sodium hydroxide; meglumine; lactose monohydrate; iron oxide red - teltartan hct is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: meglumine; lactose monohydrate; povidone; magnesium stearate; crospovidone; colloidal anhydrous silica; sodium hydroxide - telmisartan is indicated for:,treatment of hypertension ,prevention of cardiovascular morbidity and mortality in patients 55 years or older with,coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic,attack or high risk diabetes with evidence of end organ damage.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: magnesium stearate; crospovidone; lactose monohydrate; meglumine; colloidal anhydrous silica; sodium hydroxide; povidone - telmisartan is indicated for:,treatment of hypertension ,prevention of cardiovascular morbidity and mortality in patients 55 years or older with,coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic,attack or high risk diabetes with evidence of end organ damage.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - hydrochlorothiazide, quantity: 25 mg; telmisartan, quantity: 80 mg - tablet, multilayer - excipient ingredients: meglumine; sodium hydroxide; mannitol; povidone; magnesium stearate; lactose monohydrate; purified water; sodium stearylfumarate; colour - apo telmisartan hctz is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - telmisartan, quantity: 80 mg - tablet - excipient ingredients: sodium stearylfumarate; magnesium stearate; mannitol; meglumine; sodium hydroxide; povidone - apo-telmisartan is indicated for:,treatment of hypertension,prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: sodium hydroxide; povidone; meglumine; mannitol; magnesium stearate - telmisartan is indicated for: treatment of hypertension. prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials).

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: magnesium stearate; meglumine; mannitol; sodium hydroxide; povidone - telmisartan is indicated for: treatment of hypertension. prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials).

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: meglumine; sodium hydroxide; magnesium stearate; mannitol; povidone - telmisartan is indicated for: treatment of hypertension. prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials).